Detalhe da pesquisa
1.
BET inhibitors induce NF-κB and E2F downregulation in Hodgkin and Reed-Sternberg cells.
Exp Cell Res
; 430(2): 113718, 2023 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37468057
2.
Low-risk HPLLs/ABC score patients with splenic marginal zone lymphoma can be safely managed without treatment: Results from a prospective Spanish study.
Br J Haematol
; 202(4): 776-784, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37386877
3.
Autologous stem-cell transplantation as consolidation of first-line chemotherapy in patients with peripheral T-cell lymphoma: a multicenter GELTAMO/FIL study.
Haematologica
; 107(11): 2675-2684, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35320921
4.
Evaluation of the MD Anderson tumor score for diffuse large B-cell lymphoma in the rituximab era.
Eur J Haematol
; 104(5): 400-408, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-31804029
5.
Synthesis and anticancer activity of open-resorcinarene conjugates.
Bioorg Med Chem Lett
; 30(14): 127275, 2020 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32527536
6.
Differential prognostic impact of GELTAMO-IPI in cell of origin subtypes of Diffuse Large B Cell Lymphoma as defined by the Hans algorithm.
Br J Haematol
; 182(4): 534-541, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29978453
7.
Validation of the NCCN-IPI for diffuse large B-cell lymphoma (DLBCL): the addition of ß2 -microglobulin yields a more accurate GELTAMO-IPI.
Br J Haematol
; 176(6): 918-928, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28106247
8.
Hepatitis C virus-related lymphoproliferative disorders encompass a broader clinical and morphological spectrum than previously recognized: a clinicopathological study.
Mod Pathol
; 27(2): 281-93, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23929267
9.
Long-term results of a phase 2 study of rituximab and bendamustine for mucosa-associated lymphoid tissue lymphoma.
Blood
; 130(15): 1772-1774, 2017 10 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28801448
10.
Branched clonal evolution: nodal follicular lymphoma and primary diffuse large B-cell lymphoma of the central nervous system.
Haematologica
; 104(7): e326-e329, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30890596
11.
Circulating tumor DNA for monitoring classic Hodgkin lymphoma patients: Correlation with FDG-PET/CT.
EJHaem
; 5(1): 70-75, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38406538
12.
Immune and stromal transcriptional patterns that influence the outcome of classic Hodgkin lymphoma.
Sci Rep
; 14(1): 710, 2024 01 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38184757
13.
MicroRNA signatures and treatment response in patients with advanced classical Hodgkin lymphoma.
Br J Haematol
; 162(3): 336-47, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23725219
14.
miRNA expression in diffuse large B-cell lymphoma treated with chemoimmunotherapy.
Blood
; 118(4): 1034-40, 2011 Jul 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-21633089
15.
JAK/STAT blockade reverses the malignant phenotype of Hodgkin and Reed-Sternberg cells.
Blood Adv
; 7(15): 4135-4147, 2023 08 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36459489
16.
Comments on the value International Prognostic Score (IPS), stage IV and age over 45 years, for the outcome of advanced Hodgkin lymphoma in chemotherapy containing adriamycin. The experience of the Spanish Hodgkin Lymphoma Study Group.
Br J Haematol
; 178(2): 336-338, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27135208
17.
Risk stratification for Splenic Marginal Zone Lymphoma based on haemoglobin concentration, platelet count, high lactate dehydrogenase level and extrahilar lymphadenopathy: development and validation on 593 cases.
Br J Haematol
; 159(2): 164-71, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22924582
18.
A molecular risk score based on 4 functional pathways for advanced classical Hodgkin lymphoma.
Blood
; 116(8): e12-7, 2010 Aug 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-20479282
19.
Immunohistochemical markers for tumor associated macrophages and survival in advanced classical Hodgkin's lymphoma.
Haematologica
; 97(7): 1080-4, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22315492
20.
The Hodgkin Lymphoma Immune Microenvironment: Turning Bad News into Good.
Cancers (Basel)
; 14(5)2022 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35267668